Delayed Severe Drug Induced Cholestasis After Anabolic Steroids Exposure
2018
- 356Usage
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Usage356
- Downloads304
- Abstract Views52
Artifact Description
Anabolic steroids therapy is linked to a distinctive form of acute cholestasis that generally arises within 1 to 4 months of starting therapy but may be delayed to as long as 6 to 24 months in some reported cases. We are presenting an unusual case where acute cholestasis happened 5 weeks after discontinuing short course (7 days) of anabolic steroids.A 20-year-old African American male without significant past medical history presented with jaundice, mild nausea and generalized pruritis. He admitted to self-initiation of oral Stanozolol 40 mg daily for 7-days about 5 weeks before his admission. No prior incidence and no significant alcohol use. Vitals signs unremarkable and physical exam was unremarkable except for jaundice and sclera icterus. No hepatosplenomegaly. Liver function profile with ALT 44 IU/L, AST 72 IU/L, ALP 266 IU/L, & total bilirubin of 21.4 mg/Dl. Extensive hepatitis workup was negative and a CT-guided liver biopsy was performed which showed marked hepatocanalicular cholestasis. This is reflective of drug induced cholestasis.Our case highlights the possibility of delayed liver injury even after a short anabolic steroids course which typically happen while taking the medication for an extended period (more than 1 month).
Bibliographic Details
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know